...
首页> 外文期刊>Cardiology >Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
【24h】

Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study

机译:老年非ST-EXT-EXTIVATION心肌梗死后侵入性或保守策略后的长期存活:一项潜在的队列研究

获取原文
获取原文并翻译 | 示例

摘要

Background: The optimal management of elderly patients with non-ST-segment elevation myocardial infarction (NSTEMI) is still discussed. We aimed to study short- and long-term survival in NSTEMI patients >= 75 years managed with an invasive or a conservative strategy. Methods: NSTEMI patients admitted to Oslo University Hospital Ulleval during 2005-2011 were included consecutively in a prospective registry. Vital status until December 31, 2013, was obtained from the Norwegian Cause of Death Registry. Patients >= 75 years were identified, and 30-day and 7-year survival were analyzed. Logistic- and Cox regression was used to estimate OR and hazard ratio (HR) for death in the invasive versus conservative group, adjusting for registered confounders. Results: There were 2,064 NSTEMI patients >= 75 years (48.2% women); 1,200 (58.1%) were treated with an invasive strategy, and were younger, more likely to be male and previously revascularized compared to 864 (41.9%) patients treated conservatively (p = 75 years, 30-day survival was 95%, and 7-year survival was 47% with an invasive strategy. Revascularized patients had a superior long-term prognosis. With a conservative strategy, short- and long-term survival was lower, probably due to selection bias and unmeasured confounding.
机译:背景:仍然讨论了老年非ST段升高患者(NSTemi)的老年患者的最佳管理。我们旨在研究NSTemi患者的短期和长期存活> = 75年以侵入性或保守策略管理。方法:在2005 - 2011年期间,在2005 - 2011年期间占奥尔洛大学医院乌利尔瓦尔的Nstemi患者在潜在的注册处包括连续。至2013年12月31日至2013年12月31日,从挪威丧生登记处获得了重要地位。鉴定患者> = 75岁,分析了30天和7年的存活。逻辑和Cox回归用于估计或危害侵袭与保守群体中死亡的危害(HR),调整注册混淆。结果:有2,064名Nstemi患者> = 75岁(女性48.2%); 1,200(58.1%)用侵袭性策略治疗,更年轻,更可能是男性和以前血管化,而864(41.9%)患者保守治疗(P = 75岁,30天存活率为95%,7 - 年生存率为47%,侵入策略。血运重建患者具有优异的长期预后。具有保守的策略,短期和长期存活率较低,可能是由于选择偏见和未测量的混淆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号